SEC reporting owner
| Reporting owner CIK | 0001760669 |
|---|---|
| Issuers | 3 |
| Qualifying disclosures | 486 |
| Public purchases | 0 |
| Recent-window purchases | 0 |
| Recent-window sales | 12 |
| Last public filing | 2026-10-16 |
| Coverage | verified |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-10-16 | 2026-10-15 | MRNA | S | 39,145 | Not reported |
| 2026-10-16 | 2026-10-14 | MRNA | S | 450 | Not reported |
| 2026-10-16 | 2026-10-14 | MRNA | S | 38,774 | Not reported |
| 2026-09-16 | 2026-09-15 | MRNA | S | 40,281 | Not reported |
| 2026-09-16 | 2026-09-14 | MRNA | S | 40,294 | Not reported |
| 2026-07-16 | 2026-07-15 | MRNA | S | 53,336 | Not reported |
| 2026-06-17 | 2026-06-15 | MRNA | S | 53,336 | Not reported |
| 2026-05-18 | 2026-05-15 | MRNA | S | 53,336 | Not reported |
| 2026-03-03 | 2026-03-01 | MRNA | A | 165,230 | Not reported |
| 2026-03-03 | 2026-03-01 | MRNA | A | 125,466 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.